These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8123230

  • 1. Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile.
    Ogren SO, Lundström J, Nilsson LB.
    J Neural Transm Gen Sect; 1993; 94(3):199-216. PubMed ID: 8123230
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.
    Ogren SO, Lundström J, Nilsson LB, Widman M.
    J Neural Transm Gen Sect; 1993; 93(3):187-203. PubMed ID: 8217058
    [Abstract] [Full Text] [Related]

  • 3. Effects of remoxipride's metabolites on dopamine D2 receptors and receptor functions in the rat.
    Ogren SO, Hall H, Widman M, Angeby-Möller K.
    Pharmacol Toxicol; 1993 Dec; 73(6):325-34. PubMed ID: 8153056
    [Abstract] [Full Text] [Related]

  • 4. In vivo effects of remoxipride and aromatic ring metabolites in the rat.
    Ahlenius S, Ericson E, Hillegaart V, Nilsson LB, Salmi P, Wijkström A.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1356-66. PubMed ID: 9400011
    [Abstract] [Full Text] [Related]

  • 5. The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
    Ogren SO, Rosén L, Fuxe K.
    Neuroscience; 1994 Jul; 61(2):269-83. PubMed ID: 7969908
    [Abstract] [Full Text] [Related]

  • 6. Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain.
    Köhler C, Radesäter AC, Karlsson-Boethius G, Bryske B, Widman M.
    J Neural Transm Gen Sect; 1992 Jul; 87(1):49-62. PubMed ID: 1531593
    [Abstract] [Full Text] [Related]

  • 7. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M, Shirakawa K, Matsuoka N, Mutoh S.
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [Abstract] [Full Text] [Related]

  • 8. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Angeby K, Florvall L.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):459-74. PubMed ID: 6149133
    [Abstract] [Full Text] [Related]

  • 9. Involvement of presynaptic 5-HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats.
    Mombereau C, Arnt J, Mørk A.
    Pharmacol Biochem Behav; 2017 Feb 20; 153():141-146. PubMed ID: 28057524
    [Abstract] [Full Text] [Related]

  • 10. Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile.
    Ogren SO, Archer T.
    Psychopharmacology (Berl); 1994 Apr 20; 114(3):383-91. PubMed ID: 7855196
    [Abstract] [Full Text] [Related]

  • 11. Neurochemical effects of prolonged treatment with remoxipride as assessed by intracerebral microdialysis in freely moving rats.
    Georgieva J, Mohringe B, Magnusson O.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov 20; 18(7):1187-201. PubMed ID: 7846288
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of the dopamine D2 selective receptor antagonist remoxipride on dopamine turnover in the rat brain after acute and repeated administration.
    Magnusson O, Mohringe B, Thorell G, Lake-Bakaar DM.
    Pharmacol Toxicol; 1987 May 20; 60(5):368-73. PubMed ID: 2886989
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
    Erosa-Rivero HB, Bata-García JL, Alvarez-Cervera FJ, Heredia-López FJ, Góngora-Alfaro JL.
    Neuropharmacology; 2014 Jun 20; 81():176-87. PubMed ID: 24534110
    [Abstract] [Full Text] [Related]

  • 20. Neuropharmacological and behavioural properties of remoxipride in the rat.
    Ogren SO, Florvall L, Hall H, Magnusson O, Angeby-Möller K.
    Acta Psychiatr Scand Suppl; 1990 Jun 20; 358():21-6. PubMed ID: 1978483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.